The Centers for Disease Control and Prevention (CDC), Office of Acquisitions, intend to award a sole source purchase order in accordance with FAR Part 13.106-1(b)(1), to EMD Millipore Corporation. 400 Summit Drive, Burlington MA, 01803 for xMap Intelliflex System, that utilizes xMAP technology. xMAP Intelliflex readers have been validated for use in quantifying specific serologic for 500 disease targets and continued use of this reader is needed to maintain compatibility with existing standard operating procedures and to harmonize surveillance platforms with collaborating labs globally. To ensure research using xMAP technology can continue within the Serology Section, CDC need to acquire the current model instrument. 

No request for quote will be issued based upon this notice of intent. This synopsis ends in 3 days in accordance with FAR 5.203 (a)(1). Any interested companies are welcome to submit their ability to provide the specified products via email to [email protected]. Please include reference number (2022-67961) and respond by July 8, 2022 at 2 PM EST. Responses received will be considered for future procurements. A determination by the Government not to compete the proposed procurement is solely within the discretion of the Government.